Musa Cura, Ahmet Koç, Nurten Aksoy, and Zeynep Canan Özdemir
Blood Res 2016; 51(4): 261-267Eun Young Joo, Keun Young Kim, Dong Hyun Kim, Ji-Eun Lee, and Soon Ki Kim
Blood Res 2016; 51(4): 268-273Abdularahman B.O. Mohamed, Salwa Ibrahim Hindawi, Sameer Al-harthi, Qamre Alam, Mohammad Zubair Alam, Absarul Haque, Waseem Ahmad, and Ghazi A Damanhouri
Blood Res 2016; 51(4): 274-278Sang Hyuk Park, Eun Yup Lee, and Ho-Jin Shin
Blood Res 2016; 51(4): 279-281Hyunseop Kwon, Hyun Hee Lee, Chung Ryul Paik, Yun-Jeong Lim, and Jeong A. Park
Blood Res 2016; 51(4): 281-285Min-Seok Cho, Jae Yong Kim, Seung-Yeon Jung, Seo-Yeon Ahn, Ga young Song, and Deok-Hwan Yang
Blood Res 2016; 51(4): 285-287Preetesh Jain, Suhair A. Al Salihi, Rodrigo Hasbun, Harinder S. Juneja, Nghia D. Nguyen, and Modupe Idowu
Blood Res 2016; 51(4): 288-290Anila Rashid, Mohammad Akbar Agha, Saima Minhas, Bipin Nepal, and Nadeem Nusrat
Blood Res 2016; 51(4): 290-292Jansen N. Seheult, Merete Eis Lund, Mark H. Yazer, and Kjell Titlestad
Blood Res 2016; 51(4): 293-296Chul Won Jung, Su-Hee Cho, Sylvia Park, Jun Ho Jang, and Jun Ho Ji
Blood Res 2016; 51(4): 297-299
Platelet count after alemtuzumab treatment.
Abbreviations: Pt1, patient 1; Pt2, patient 2.
|@|~(^,^)~|@|CD4+, CD8+, CD4+/CD25+ lymphocyte count after alemtuzumab treatment. (A) CD4+ lymphocyte, (B) CD8+ lymphocyte, (C) CD4+/CD25+ lymphocyte.
Abbreviations: Pt1, patient 1; Pt2, patient 2.